Total Payments
$4,545
2023 Payments
$70.79
Companies
20
Transactions
82
Medicare Patients
894
Medicare Billing
$89,956

Payment Breakdown by Category

Food & Beverage$2,240 (49.3%)
Research$1,265 (27.8%)
Travel$1,040 (22.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,240 70 49.3%
Unspecified $1,265 8 27.8%
Travel and Lodging $1,040 4 22.9%

Payments by Type

General
$3,280
74 transactions
Research
$1,265
8 transactions

Top Paying Companies

Company Total Records Latest Year
AbbVie, Inc. $1,265 8 $0 (2017)
Abbott Laboratories $1,187 7 $0 (2017)
ACADIA Pharmaceuticals Inc $482.36 6 $0 (2020)
Boston Scientific Corporation $252.57 4 $0 (2023)
UCB, Inc. $204.66 13 $0 (2020)
Teva Pharmaceuticals USA, Inc. $152.04 9 $0 (2020)
Sunovion Pharmaceuticals Inc. $148.73 4 $0 (2020)
Eisai Inc. $125.78 2 $0 (2017)
Amgen Inc. $124.03 2 $0 (2018)
Adamas Pharmaceuticals, Inc. $115.30 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $70.79 1 Boston Scientific Corporation ($70.79)
2022 $146.66 1 Boston Scientific Corporation ($146.66)
2020 $245.71 9 ACADIA Pharmaceuticals Inc ($112.14)
2019 $607.39 28 UCB, Inc. ($152.40)
2018 $490.56 12 Amgen Inc. ($124.03)
2017 $2,984 31 AbbVie, Inc. ($1,265)

All Payment Transactions

82 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/14/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $70.79 General
Category: General - DBS_NMD
09/30/2022 Boston Scientific Corporation General - DBS (Device) Food and Beverage In-kind items and services $146.66 General
Category: General - DBS_NMD
11/20/2020 Allergan, Inc. BOTOX (Biological) Food and Beverage In-kind items and services $20.87 General
Category: HYPERHYDROSIS
06/18/2020 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $13.86 General
Category: CNS
06/04/2020 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $20.60 General
Category: Central Nervous System
04/16/2020 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $16.80 General
Category: Central Nervous System
03/09/2020 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $112.14 General
Category: PARKINSONS DISEASE PSYCHOSIS
03/05/2020 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $11.45 General
Category: Central Nervous System
02/07/2020 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $11.57 General
Category: NEUROLOGY
01/31/2020 Akcea Therapeutics, Inc. TEGSEDI (Drug) Food and Beverage In-kind items and services $15.97 General
Category: NEUROLOGY
01/02/2020 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $22.45 General
Category: Neurology
12/19/2019 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $22.94 General
Category: Immunology
12/19/2019 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $15.53 General
Category: Immunology
12/05/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $20.19 General
Category: Neurology
12/05/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $16.25 General
Category: NEUROLOGY
11/21/2019 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $14.32 General
Category: Neurology
11/07/2019 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $21.05 General
Category: Immunology
10/31/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $25.60 General
Category: Neurology
10/31/2019 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Central Nervous System
09/19/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $22.10 General
Category: Neurology
08/29/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $16.20 General
Category: Neurology
07/18/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $12.35 General
Category: Neurology
06/20/2019 Sunovion Pharmaceuticals Inc. APTIOM (Drug) Food and Beverage In-kind items and services $105.19 General
Category: CNS
06/20/2019 UCB, Inc. Neupro (Drug) Food and Beverage In-kind items and services $8.26 General
Category: Neurology
06/13/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage In-kind items and services $16.69 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 218 305 $82,153 $23,485
2022 9 231 345 $92,720 $26,135
2021 8 181 265 $62,821 $18,792
2020 7 264 365 $75,418 $21,545
Total Patients
894
Total Services
1,280
Medicare Billing
$89,956
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 55 77 $16,542 $5,191 31.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 38 39 $11,565 $4,012 34.7%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Facility 2023 16 34 $18,767 $3,893 20.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 24 24 $11,422 $3,164 27.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 20 32 $5,024 $1,953 38.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $5,915 $1,606 27.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 12 17 $3,859 $1,500 38.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 15 15 $5,901 $1,415 24.0%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Facility 2023 25 54 $3,158 $751.23 23.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 65 94 $21,994 $6,660 30.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 33 55 $12,485 $4,312 34.5%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Facility 2022 16 35 $19,670 $3,771 19.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 30 49 $7,693 $2,677 34.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 15 16 $7,433 $2,435 32.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 19 19 $6,367 $2,034 32.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 13 13 $6,536 $1,838 28.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 18 18 $7,710 $1,787 23.2%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Facility 2022 22 46 $2,832 $621.26 21.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 65 92 $20,700 $6,549 31.6%
64616 Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin Facility 2021 12 29 $12,408 $3,507 28.3%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 23 26 $7,930 $2,873 36.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 21 33 $5,181 $1,826 35.2%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 12 12 $5,220 $1,575 30.2%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 17 17 $6,534 $1,223 18.7%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 15 16 $2,448 $627.60 25.6%

About Dr. Zain Guduru, M.D

Dr. Zain Guduru, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1215291398.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zain Guduru, M.D has received a total of $4,545 in payments from pharmaceutical and medical device companies, with $70.79 received in 2023. These payments were reported across 82 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,240).

As a Medicare-enrolled provider, Guduru has provided services to 894 Medicare beneficiaries, totaling 1,280 services with total Medicare billing of $89,956. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

Products in Payments

  • DBS IPGs (Device) $1,187
  • NUPLAZID (Drug) $482.36
  • Neupro (Drug) $157.73
  • AUSTEDO (Drug) $152.04
  • APTIOM (Drug) $148.73
  • General - DBS (Device) $146.66
  • Fycompa (Drug) $125.78
  • GOCOVRI (Drug) $115.30
  • ACTIVA (Device) $107.49
  • Hizentra (Biological) $107.01
  • NORTHERA (Drug) $73.36
  • RYTARY (Drug) $54.71
  • INGREZZA (Drug) $49.50
  • Briviact (Drug) $46.93
  • VERCISE (Device) $35.12
  • GILENYA (Drug) $27.40
  • BOTOX (Biological) $20.87
  • AIMOVIG (Biological) $16.69
  • TEGSEDI (Drug) $15.97
  • QUDEXY XR Topiramate Extended Release Capsules (Drug) $14.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Lexington